Eris Lifesciences designates Gopal Agrawal, Nita Borkar in leadership roles Ruchika Sharma2 April 2025 1:16 PM ISTMumbai: Eris Lifesciences Limited, an Indian branded formulations manufacturing company, has designated Gopal Agrawal and Nita Borkar in...
Eris Lifesciences gets CDSCO Panel nod To Initiate Phase III CT of Esaxerenone Tablets Dr. Divya Colin30 March 2025 6:00 PM ISTNew Delhi: Based on the bioequivalence (BE) study of the new drug Esaxerenone Tablets 1.25, 2.5 and 5 mg, the Subject Expert Committee (SEC)...
Eris Lifesciences transfers 100% stake in 2 arms to Eris Therapeutics for Rs 861.9 crore Ruchika Sharma7 March 2025 2:30 PM ISTAhmedabad: Eris Lifesciences has announced that the Company has transferred 100 percent of its holdings in two wholly-owned subsidiaries to...
Eris Lifesciences ropes in Murari Ranganathan as President, Cardiometabolic Business Ruchika Sharma6 March 2025 12:21 PM ISTMumbai: Eris Lifesciences Limited, a Indian branded formulations manufacturing company, has appointed Murari Ranganathan as President,...
Six Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel Farhat Nasim4 Dec 2024 5:00 PM ISTNew Delhi: Over the last five years, six pharmaceutical suppliers have been blacklisted for providing substandard medicines to Jan Aushadhi Kendras...
Submit Source Data of Phase III CT Report: CDSCO Panel Tells Eris Lifesciences on Metoprolol Succinate plus Dapagliflozin FDC Dr. Divya Colin11 May 2024 6:00 PM ISTNew Delhi: Reviewing the Phase III clinical trial report of fixed-dose combination (FDC) drug, Metoprolol Succinate sustained released 25mg/50mg plus...
Eris Lifesciences acquires Biocon Biologics India branded formulation business for Rs 1242 crore Susmita Roy15 March 2024 1:51 PM ISTMumbai: Eris Lifesciences Ltd., a branded formulations company, has announced the acquisition of Biocon Biologics' India branded formulation...
Eris buys 51 percent stake in Swiss Parenterals for Rs 637.5 crore Ruchika Sharma14 Feb 2024 3:33 PM ISTNew Delhi: Eris Lifesciences has said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore.Ahmedabad-based Swiss Parenterals is...
Biocon Biologics to divest dermatology, nephrology branded formulations business units in India to Eris Lifesciences for Rs 366 crore Ruchika Sharma9 Nov 2023 11:45 AM ISTThe divestiture is expected to close by the end of Nov 2023, subject to customary closing conditions.
Eris Lifesciences acquires 9 Dermatology brands from Dr Reddy's Labs for Rs 275 crore Ruchika Sharma17 March 2023 11:38 AM ISTThe brands are largely in cosmetology segments like anti-acne, moisturisers, cleansers, anti-ageing, hair health, melasma etc.
Eris Lifesciences to acquire Onabet, Halobate and 7 other dermatology brands from Glenmark Pharma for over Rs 338 crore Ruchika Sharma19 Jan 2023 11:45 AM ISTBengaluru: Indian drugmaker Eris Lifesciences Ltd said on Tuesday it would acquire a portfolio of dermatology brands from Glenmark...
Combinations of 45 medicines fixed, including Sitagliptin- Metformin, Linagliptin -Metformin combinations Ruchika Sharma25 Aug 2022 5:00 PM ISTNew Delhi: Through a recent notice, The National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India...
